Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  donor lymphocytes
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-19 of 19 for your search:
Start Over
A Two-Step Approach to Bone Marrow Transplant Using Cells From A Partially-Matched Relative
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 06U.20, 2005-84, NCT00429143
Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic Transplantation
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 18 to 60
Sponsor: Other
Protocol IDs: EK126092000, NCT00460629
Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological Malignancies
Phase: Phase II, Phase I
Type: Treatment
Status: Completed
Age: 12 to 60
Sponsor: Other
Protocol IDs: CIK#2/2007, NMRC/1097/2006, NCT00460694
Mixed Chimera Allo Transplantation in Multiple Myeloma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: BMT109, 75190, NCT00185614
Mismatched Donor Lymphocyte Infusions for Relapsed Disease Following Allogeneic Stem Cell Transplantation
Phase: Phase II
Type: Treatment
Status: Completed
Age: 8 to 75
Sponsor: NHLBI
Protocol IDs: 090087, 09-H-0087, NCT00859586
A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies
Phase: Phase II
Type: Supportive care, Treatment
Status: Closed
Age: 6 months to 25 years
Sponsor: Other
Protocol IDs: CC# 09082, NCT01036009
Donor Stem Cell Transplant in Treating Patients With Relapsed Hematologic Malignancies or Secondary Myelodysplasia Previously Treated With High-Dose Chemotherapy and Autologous Stem Cell Transplant
Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Closed
Age: Under 70
Sponsor: NCI, Other
Protocol IDs: CDR0000667954, CALGB-100601, NCT01118013
Clofarabine/Ara-C Treatment Combined With Reduced-intensity Conditioning Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia in Primary Treatment Failure
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 to 55
Sponsor: Other
Protocol IDs: BRD 09/6-C, NCT01188174
Enhancing Graft vs Leukemia Via Delayed Ex-Vivo Co-Stimulated DLI After Non-Myeloablative Stem Cell Transplantation
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 to 70
Sponsor: Other
Protocol IDs: UPCC 08405, NCT00374933
Safety Trial of NK DLI From 6/6 HLA Matched Family Member Following Nonmyeloablative ASCT
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Pro00005124, NCT00586690
Safety Trial of NK Cell DLI 3-5/6 Family Member Following Nonmyeloablative ASCT
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: Pro00005123, NCT00586703
Infusion of Donor Lymphocytes Depleted of CD25+ Regulatory T-cells in Patients With Relapsed Hematologic Malignancies
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 07-193, NCT00675831
Safety Study of Liver Natural Killer Cell Therapy for Hepatoma Liver Transplantation
Phase: Phase I
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Other
Protocol IDs: 20100344, NCT01147380
Donor Th2 Cells to Prevent Graft-Versus-Host Disease in Bone Marrow Transplants
Phase: Phase I
Type: Supportive care
Status: Completed
Age: 18 to 75
Sponsor: NCI
Protocol IDs: 990143, 99-C-0143, NCT00001830
Donor Lymphocyte Infusion in Treating Patients With Recurrent or Persistent Hematologic Cancer After Donor Stem Cell Transplant
Phase: No phase specified
Type: Treatment
Status: Closed
Age: Under 76
Sponsor: Other
Protocol IDs: CDR0000564827, RPCI-I-00703, I 00703, NCT00534118
Start Over